1. Home
  2. UPLD vs VTGN Comparison

UPLD vs VTGN Comparison

Compare UPLD & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$3.96

Market Cap

11.1M

Sector

Technology

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

BUY

Current Price

$0.18

Market Cap

9.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
UPLD
VTGN
Founded
2010
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
9.5M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
UPLD
VTGN
Price
$3.96
$0.18
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
★ $12.50
$1.00
AVG Volume (30 Days)
67.2K
★ 1.9M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.38
N/A
EPS
N/A
★ N/A
Revenue
★ $74,767,000.00
N/A
Revenue This Year
N/A
$33.96
Revenue Next Year
$0.58
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 6.95
N/A
52 Week Low
$0.50
$0.19
52 Week High
$6.65
$5.14

Technical Indicators

Market Signals
Indicator
UPLD
VTGN
Relative Strength Index (RSI) 56.05 31.13
Support Level $2.98 N/A
Resistance Level $4.18 $0.32
Average True Range (ATR) 0.47 0.01
MACD 0.08 -0.01
Stochastic Oscillator 85.25 4.23

Price Performance

Historical Comparison
UPLD
VTGN

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: